Laboratory evaluation and clinical characteristics of 2,132 consecutive unselected patients with venous thromboembolism - Results of the Spanish multicentric study on thrombophilia (EMET-Study)

Thrombosis and Haemostasis

Volumn 77, Issue 3, 1997, Pages 444-451

  Mateo, José ^a   Oliver, Artur ^a   Borrell, Montserrat ^a   Sala, Núria ^a   Fontcuberta, Jordi ^a,b  

^a Span Multicentric Stud T ^*  (Spain)

^b HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN; HEPARIN COFACTOR II; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY; PLASMINOGEN; PROTEIN C; PROTEIN S;

ADULT; AGED; ANTITHROMBIN DEFICIENCY; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; DYSFIBRINOGENEMIA; FAMILY HISTORY; FEMALE; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN C DEFICIENCY; PROTEIN DEFICIENCY; PROTEIN S DEFICIENCY; RISK; SPAIN; THROMBOEMBOLISM; THROMBOPHILIA; VEIN THROMBOSIS;

EID: 0030951829     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1655986     Document Type: Article

References (48)

1. Kierkegaard A. Incidence of acute deep vein thrombosis in two districts: a phlebographic study. Acta Chir Scand 1980; 146: 267-9.
2. Lane DA, Olds RR, Thein SL. Antithrombin and its deficiency states. Blood Coagul Fibrinol 1992; 3: 315-41.
3. Demers C, Ginsberg JS, Hirsh J, Henderson P, Blajchman MA. Thrombosis in antithrombin-III-deficient persons. Report of a large kindred and literature review. Ann Intern Med 1992;116:754-61.
4. Pabinger I, Kyrle PA, Heistinger M, Eichinger S, Wittmann E, Lechner K. The risk of thromboembolism in asymptomatic patients with protein C and protein S deficiency: A prospective cohort study. Thromb Haemost 1994; 71: 441-5.
5. Griffin JH, Evatt B, Zimmerman T, Kleiss A, Wideman C. Deficiency of protein C in congenital thrombotic disease. J Clin Invest 1981; 68: 1370-3.
6. Allart CF, Poort SR, Rosendaal FR, Reitsma PH, Bertina RM, Briët E. Increased risk of venous thrombosis in carriers of hereditary protein C deficiency defect. Lancet 1993; 341: 134-8.
7. Koster T, Rosendaal FR, Briët E, van der Meer FJM, Colly LP, Trienekens PH, Poort SR, Reitsma PH, Vandenbroucke JP. Protein C deficiency in a controlled series of unselected outpatients: and infrequent but clear risk factor for venous thrombosis (Leiden Thrombophilia Study). Blood 1995; 2756-61.
8. Schwartz HP, Fischer M, Hopmeier P, Batard MA, Griffin JH. Plasma protein S deficiency in familial thrombotic disease. Blood 1984; 64: 1297-300.
9. Comp PC, Nixon RR, Cooper MR, Esmon CT. Familial protein S deficiency is associated with recurrent thrombosis. J Clin Invest 1984; 74: 2082-8.
10. Engesser L, Broekmans AW, Briët E, Brommer BP, Bertina RM. Hereditary protein S deficiency: clinical manifestations. Ann Intern Med 1987; 106: 677-82.
11. Zöller B, Berntsdotter A, García de Frutos P, Dahlbäck B. Resistance to activated protein C as an additional genetic risk factor in hereditary deficiency of protein S. Blood 1995; 85: 3518-23.
12. Dahlbäck B. Protein S and C4b-binding protein: proteins involved in the regulation of the protein C anticoagulant system. Thromb Haemost 1991; 66:49-61.
13. Zöller B, García de Frutos P, Dahlbäck B. Evaluation of the relationship between protein S and C4b-binding protein isoforms in hereditary protein S deficiency demonstrating type I and type III deficiencies to be phenotypic variants of the same genetic disease. Blood 1995; 85: 3524-31.
14. Dahlbäck B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 1993; 90: 1004-8.
15. Bertina RM, Koeleman BPC, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, van der Velden PA, Reitsma PH. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64-7.
16. Dahlbäck B. Inherited thrombophilia: Resistance to activated protein C as a pathogenic factor of venous thrombosis. Blood 1995; 85: 607-14.
17. Tran TH, Marbet GH, Duckert F. Association of hereditary heparin cofactor-II deficiency with thrombosis. Lancet 1985; 2:413-4.
18. Sié P, Dupouy D, Pichon J, Boneu B. Constitutional heparin cofactor-II deficiency associated with recurrent thrombosis. Lancet 1985; 2: 414-6.
19. Aoki N, Moroi M, Sakata Y, Yoshida N. Abnormal plasminogen, a hereditary molecular abnormality found in a patient with recurrent thrombosis. J Clin Invest 1978; 61: 1186-95.
20. Scharrer IM, Wohl RC, Hach V, Sinio L, Boreisha I, Robbins KC. Investigation of a congenital abnormal plasminogen, Frankfurt I, and its relationship with thrombosis. Thromb Haemost 1986; 55: 396-401.
21. Bithell TC. Hereditary dysfibrinogenemia.Clin Chem 1985;31:509-16.
22. Bertina RM, van der Linden IK, Engesser L, Muller HP, Brommer EJ. Hereditary heparin cofactor-II deficiency and the risk of development of thrombosis. Thromb Haemostas 1987; 57: 196-200.
23. Triplett DA. Protean clinical presentation of antiphospholipid-protein antibodies. Thromb Haemost 1995; 74: 329-37.
24. Briët E, Engesser L, Brommer EJP, Broekmans AW, Bertina RM. Thrombophilia: its causes and a rough estimate of its prevalence [abstract]. Thromb Haemost 1987; 58: 39.
25. Gladson CL, Scharrer I, Hach V, Beck KH, Griffin JH. The frequency of type I heterozygous protein S and protein C deficiency in 141 unrelated young patients with venous thrombosis. Thromb Haemost 1988; 59: 18-22.
26. Ben-Tal O, Zivelin A, Seligsohn U. The relative frequency of hereditary thrombotic disorders among 107 patients with thrombophilia in Israel. Thromb Haemost 1990; 61: 50-4.
27. Engesser L, Brommer EJP, Kluft C, Briët E. Elevated plasminogen activator inhibitor (PAI), a cause of thrombophilia?. A study in 203 patients with familial or sporadic thrombophilia. Thromb Haemost 1989; 62: 673-80.
28. Heijboer H, Brandjes DPM, Büller HR, Sturk A, ten Cate LW. Deficiencies of coagulation-inhibiting and fibrinolytic proteins in outpatients with deep-vein thrombosis. N Engl J Med 1990; 323: 1512-6.
29. Tabernero MD, Tomás JF, Alberca I, Orfao A, López-Borrasca A, Vicente V. Incidence and clinical characteristics of hereditary disorders associated with venous thrombosis. Am J Hematol 1991; 36: 249-54.
30. Bick RL, Jakway J, Baker WF. Deep vein thrombosis: prevalence of etiologic factors and results of management in 100 consecutive patients. Sem Thromb Hemost 1992; 18: 267-74.
31. Melissari E, Monte G, Lindo VS, Pemberton KD, Wilson NV, Edmondson R, Das S, Kakkar VV. Congenital thrombophilia among patients with venous thromboembolism. Blood Coagul Fibrinol 1992; 3: 749-58.
32. Malm J, Laurell M, Nilsson IM, Dahlbäck B. Thromboembolic disease. Critical evaluation of laboratory investigation. Thromb Haemost 1992; 68: 2-13.
33. Pabinger I, Brücker S, Kyrie PA, Schneider B, Korninger HC, Niessner H, Lechner K. Hereditary deficiency of antithrombin III, protein C and protein S: prevalence in patients with a history of venous thrombosis and criteria for rational patient screening. Blood Coagul Fibrinol 1992;3:547-53.
34. Comp PC, Doray D, Patton D, Esmon CT. An abnormal plasma distribution of protein S occurs in functional protein S deficiency. Blood 1986; 67: 504-8.
35. Garí M, Falkon L, UrrutiaT, Vallvé C, Borrell M, Fontcuberta J. The influence of low protein S plasma levels in young women, on the definition of normal range. Thromb Res 1994; 73: 149-52.
36. Clauss A. Gerinnungsphysiologische Schenellmethode zur Bestimmung des Fibrinogens. Acta Haematol 1957; 17: 237-46.
37. Exner T, Rickard KA, Kronenberg H. A sensitive test demonstrating lupus anticoagulant and its behavioural patterns. Br J Haematol 1978; 40: 143-51.
38. Gharavi AE, Harris EN, Asherson RA, Hughes GRV. Anticardiolipin antibodies: isotype distribution and phospholipid specificity. Ann Rheum Dis 1987; 46: 1-6.
39. Tait RC, Walker ID, Perry DJ, Islam SIAM, Daly ME, McCall F, Conkie JA, Carrell RW. Prevalence of antithrombin deficiency in the healthy population. Br J Haematol 1994;87:106-12.
40. Miletich J, Sherman L, Broze G. Absence of thrombosis in subjects with heterozygous protein C deficiency. N Engl J Med 1987; 317: 991-6.
41. Kannel WB, Wolf PA, Castelli WP, D'Agostino RB. Fibrinogen and risk of cardiovascular disease; the Framingham Study. JAMA 1987; 258: 1183-6.
42. Koster T, Rosendaal FR, Reitsma PH, van der Velden PA, Briët E, Vandenbroucke JP. Factor VII and fibrinogen levels as risk factors for venous thrombosis. A case-control study of plasma levels and DNA polymorphisms. The Leiden Thrombophilia Study. Thromb Haemost 1994; 71: 719-22.
43. Vila P, Hernández MC, López-Fernández MF, Batlle J. Prevalence, follow-up and clinical significance of the anticardiolipin antibodies in normal subjects. Thromb Haemost 1994;72:209-13.
44. Forastiero RR, Kordich L, Basilotta, Carreras LO. Differences in protein S and C4b-binding protein levels in different groups of patients with antiphospholipid antibodies. Blood Coagul Fibrinol 1994; 5: 609-16.
45. Parke AL, Wilson D, Maier D. The prevalence of antiphospholipid antibodies in women with recurrent spontaneous abortion, women with successful pregnancies, and women who have never been pregnant. Arthritis Rheum 1987;30:601-6.
46. Briët E, van der Meer FJM, Rosendaal FR, Houwing-Duistermaat JJ, van Houwelingen HC. The family history and inherited thrombophilia. Br J Haematol 1994; 87: 348-52.
47. Miletich JP, Prescott SM, White R, Majerus PW, Bovill EG. Inherited predisposition to thrombosis. Cell 1993; 72: 477-80.
48. Majerus PW. Bad blood by mutation. Nature 1994; 369: 14-5.